Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

AstraZeneca
Pharmaceuticals
GSK
Sanofi
Pfizer
Topics

Advertisement

Advertisement

AstraZeneca

Share

Top Latest Popular

In the last hour

Hutchmed, AZ file Orpathys for lung cancer on ESMO data pharmaphorum 10:09

In the last 2 hours

ii view: AstraZeneca bullish on potential blockbuster assets interactive investor 09:31

Multi-year project to advance knowledge of nasal mucosal immune response Imperial College London 09:14

Advertisement

Advertisement

In the last 4 hours

Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial Pharmafile 09:06

Earlier Today

FTSE 100 logs first monthly gain in three; AstraZeneca jumps Business Recorder, Pakistan 00:06

Yesterday

AstraZeneca launches overhaul to cut costs by $1.5 billion a year Qatar Tribune 21:55 Sun, 01 Nov

AstraZeneca: 3 Key Takeaways for Long-Term Investors The Motley Fool 14:36 Sun, 01 Nov

Saturday

AstraZeneca targets $80bn revenue by 2030 with $1.5bn savings and pipeline investment EasternEye 11:00 Sat, 31 Oct

Friday

Healthcare Stocks Trade Higher: Cdna Gains 20%, Regn Adds 12%, Prof Climbs 10%, AZN Advances 7% RTT News 19:45 Fri, 30 Oct

AstraZeneca Keeps Mum On Etcamah’s US Price As European Negotiations Continue Scrip Pharma Intelligence 17:28 Fri, 30 Oct

AstraZeneca cans late-stage Ultomiris trial on lacklustre efficacy predictions Clinical Trials Arena 16:26 Fri, 30 Oct

AstraZeneca CEO strikes bullish tone on pipeline as stock rallies Gulf Times 15:05 Fri, 30 Oct

Astrazeneca (AZN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates Zacks 14:31 Fri, 30 Oct

Advertisement

FTSE 100 movers: AstraZeneca surges on results; NatWest slides ShareCast 14:24 Fri, 30 Oct

Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more STAT 13:25 Fri, 30 Oct

AstraZeneca profit jumps 23% as it unveils major savings plan euronews 12:22 Fri, 30 Oct

London midday: FTSE stays up as BT Group, AstraZeneca rally ShareCast 12:01 Fri, 30 Oct

AstraZeneca launches overhaul to cut costs by £1.1bn a year The Standard 11:45 Fri, 30 Oct

AstraZeneca results: 9M and Q3 2026 Business Wire (Press Release) 11:05 Fri, 30 Oct

AstraZeneca Trims Costs To Support Pipeline Ambitions Scrip Pharma Intelligence 11:01 Fri, 30 Oct

AstraZeneca Q3 Profit Rises; Pipeline Delivers 12 Positive Phase 3 Readouts; Stock Up RTT News 10:45 Fri, 30 Oct

Astrazeneca shares jump as it kicks off $2bn drug pipeline investment City AM 10:07 Fri, 30 Oct

AstraZeneca rises 4% as Jefferies and UBS assess profit beat Proactive Investors (US) 10:02 Fri, 30 Oct

Astrazeneca posts strong YTD beat, reiterates FY26 guidance ShareCast 09:59 Fri, 30 Oct

Astrazeneca posts solid Q3 numbers, NatWest Q3 profits slip ShareCast 09:57 Fri, 30 Oct

London open: Stocks gain as BP, AstraZeneca rise on results ShareCast 09:47 Fri, 30 Oct

AZ seeking $1.5bn in annual savings by end-2029 pharmaphorum 09:39 Fri, 30 Oct

AZ seeking $1.5bn in savings by end-2029 pharmaphorum 09:19 Fri, 30 Oct

Drugs giant AstraZeneca reveals higher profits, savings plan France 24 09:16 Fri, 30 Oct

AstraZeneca Q3 Profit Rises; Reconfirms FY26 Revenue, Core EPS Guidance At Cer RTT News 08:04 Fri, 30 Oct

AstraZeneca holds guidance as cancer drugs outrun the Farxiga generics hit Proactive Investors (US) 07:40 Fri, 30 Oct

AstraZeneca Beats Market Expectations in the Third Quarter as Revenue Reaches $16.2 Billion Sweden Herald 07:21 Fri, 30 Oct

Thursday

Veeva Summit Showcases AI and Data Innovations Advancing Agentic Commercial PR Newswire (Press Release) 11:10 Thu, 29 Oct

Wednesday

ESMO 2026: Orpathys Combo Gives MET-Resistant Tagrisso NSCLC Patients A Chemo-Free Option Scrip Pharma Intelligence 17:39 Wed, 28 Oct

AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing Business Wire (Press Release) 12:05 Wed, 28 Oct

New Abu Dhabi clinical trials using AI to have ‘massive’ impact on health care The National 03:12 Wed, 28 Oct

Tuesday

Breast Cancer Canada and AstraZeneca Canada Advance Next-Generation Survivorship Research Business Wire (Press Release) 18:45 Tue, 27 Oct

AstraZeneca May Enter Cancer Vaccine Development, CEO Says Bloomberg Law 17:44 Tue, 27 Oct

AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over Pharmafile 15:06 Tue, 27 Oct

AstraZeneca offers compelling risk-reward into 2027 pipeline readouts, says JPMorgan Proactive Investors (US) 14:31 Tue, 27 Oct

Advertisement

My Local News

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis